{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T17:34:33Z","timestamp":1772213673683,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.clgc.2025.102428","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T15:56:45Z","timestamp":1756828605000},"page":"102428","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Long-Term Mortality Trends From Prostate Cancer and Associated Second Malignancies in the U.S., 1999 to 2023: Implications for Survivorship Care"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-4273-0827","authenticated-orcid":false,"given":"Shree","family":"Rath","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amar","family":"Lal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8425-6395","authenticated-orcid":false,"given":"Ahmed","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laiba","family":"Sultan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mishaim","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umama","family":"Alam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.clgc.2025.102428_bib0001","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.ijrobp.2014.07.032","article-title":"Incidence of second malignancies in prostate cancer patients treated with low-dose-rate brachytherapy and radical prostatectomy","volume":"90","author":"Hamilton","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1016\/j.clgc.2025.102428_bib0002","series-title":"Cancer Statistics Prostate Cancer Stat Bite","year":"2025"},{"issue":"11","key":"10.1016\/j.clgc.2025.102428_bib0003","doi-asserted-by":"crossref","first-page":"5752","DOI":"10.1002\/cam4.1764","article-title":"Prostate cancer survivors: risk and mortality in second primary cancers","volume":"7","author":"Chattopadhyay","year":"2018","journal-title":"Cancer Med"},{"key":"10.1016\/j.clgc.2025.102428_bib0004","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s00066-024-02288-6","article-title":"The risk of second malignancies following prostate cancer radiotherapy in the era of conformal radiotherapy: a statement of the Prostate Cancer Working Group of the German Society of Radiation Oncology (DEGRO)","volume":"201","author":"Zamboglou","year":"2025","journal-title":"Strahlenther Onkol"},{"issue":"8","key":"10.1016\/j.clgc.2025.102428_bib0005","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/jamaoncol.2023.1638","article-title":"Comparing risk for second primary cancers after intensity-modulated vs 3-dimensional conformal radiation therapy for prostate cancer, 2002-2015","volume":"9","author":"Pithadia","year":"2023","journal-title":"JAMA oncology"},{"key":"10.1016\/j.clgc.2025.102428_bib0006","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/s41598-020-80534-4","article-title":"Clinical characteristics and overall survival nomogram of second primary malignancies after prostate cancer, a SEER population-based study","volume":"11","author":"Liu","year":"2021","journal-title":"Sci Rep"},{"issue":"62","key":"10.1016\/j.clgc.2025.102428_bib0007","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/jncimonographs\/lgad018","article-title":"Racial disparities in prostate cancer mortality: a model-based decomposition of contributing factors","author":"Gulati","year":"2023","journal-title":"JNCI Monographs"},{"key":"10.1016\/j.clgc.2025.102428_bib0008","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3389\/fonc.2019.00238","article-title":"Geographical variations in prostate cancer outcomes: a systematic review of international evidence","volume":"9","author":"Dasgupta","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.clgc.2025.102428_bib0009","unstructured":"CDC WONDER. Centers for Disease Control and Prevention. U.S. https:\/\/wonder.cdc.gov\/."},{"key":"10.1016\/j.clgc.2025.102428_bib0010","unstructured":"Multiple cause of death data on CDC WONDER. U.S.: Centers for Disease Control and Prevention. U.S. https:\/\/wonder.cdc.gov\/mcd.htm."},{"issue":"5","key":"10.1016\/j.clgc.2025.102428_bib0011","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.4103\/sja.SJA_543_18","article-title":"The STROBE guidelines","volume":"13","author":"Cuschieri","year":"2019","journal-title":"Saudi J Anaesth"},{"key":"10.1016\/j.clgc.2025.102428_bib0012","first-page":"1","article-title":"NCHS urban-rural classification scheme for counties","volume":"154","author":"Ingram","year":"2012","journal-title":"Vital Health Stat 2"},{"key":"10.1016\/j.clgc.2025.102428_bib0013","unstructured":"Geographic division or region - Health, United States. National Center for Health Statistics (U.S. https:\/\/www.cdc.gov\/nchs\/hus\/sources-definitions\/geographic-region.htm. [Accessed 25 December 2024]."},{"key":"10.1016\/j.clgc.2025.102428_bib0014","article-title":"National vital statistics reports","volume":"47","author":"Anderson","year":"1998"},{"key":"10.1016\/j.clgc.2025.102428_bib0015","author":"Surveillance Research Program"},{"issue":"1","key":"10.1016\/j.clgc.2025.102428_bib0016","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12957-025-03733-1","article-title":"Global burden of prostate cancer: age-period-cohort analysis from 1990 to 2021 and projections until 2040","volume":"23","author":"Chu","year":"2025","journal-title":"World J Surg Onc"},{"issue":"6","key":"10.1016\/j.clgc.2025.102428_bib0017","first-page":"11384","article-title":"Increasing aggressive prostate cancer","volume":"29","author":"Shah","year":"2022","journal-title":"Can J Urol"},{"key":"10.1016\/j.clgc.2025.102428_bib0018","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.11869","article-title":"Association of the USPSTF grade D recommendation against prostate-specific antigen screening with prostate cancer\u2013specific mortality","volume":"5","author":"Burgess","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.clgc.2025.102428_bib0019","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.radonc.2013.12.012","article-title":"Second primary cancers after radiation for prostate cancer: A systematic review of the clinical data and impact of treatment technique","volume":"110","author":"Murray","year":"2014","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.clgc.2025.102428_bib0020","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00345-018-2407-3","article-title":"Unintended consequences of decreased PSA-based prostate cancer screening","volume":"37","author":"Ahlering","year":"2019","journal-title":"World J Urol"},{"issue":"3","key":"10.1016\/j.clgc.2025.102428_bib0021","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000356115","article-title":"Radiation-induced secondary malignancy in prostate cancer: a systematic review and meta-analysis","volume":"93","author":"Jin","year":"2014","journal-title":"Urol Int"},{"issue":"12","key":"10.1016\/j.clgc.2025.102428_bib0022","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1001\/jamaoncol.2022.4319","article-title":"Association of prostate-specific antigen screening rates with subsequent metastatic prostate cancer incidence at us veterans health administration facilities","volume":"8","author":"Bryant","year":"2022","journal-title":"JAMA Oncol"},{"issue":"e2","key":"10.1016\/j.clgc.2025.102428_bib0023","doi-asserted-by":"crossref","first-page":"e1594","DOI":"10.1136\/spcare-2023-004310","article-title":"COVID-19 pandemic impact on screening and diagnosis of prostate cancer: a systematic review","volume":"14","author":"Mostafavi Zadeh","year":"2024","journal-title":"BMJ Support Palliat Care"},{"issue":"Suppl_2","key":"10.1016\/j.clgc.2025.102428_bib0024","doi-asserted-by":"crossref","first-page":"S233","DOI":"10.2337\/dcS13-2001","article-title":"Epidemiology and molecular mechanisms tying obesity, diabetes, and the metabolic syndrome with cancer","volume":"36","author":"Gallagher","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clgc.2025.102428_bib0025","series-title":"Obesity and Severe Obesity Prevalence in Adults: United States, August 2021\u2013August 2023","author":"Emmerich","year":"2024"},{"key":"10.1016\/j.clgc.2025.102428_bib0026","series-title":"National diabetes statistics report","year":"2024"},{"key":"10.1016\/j.clgc.2025.102428_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2025.112012","article-title":"CDC WONDER: trends in diabetes mellitus mortality in the United States from 1968 to 2021","volume":"221","author":"Waqas","year":"2025","journal-title":"Diab Res Clin Pract"},{"issue":"10","key":"10.1016\/j.clgc.2025.102428_bib0028","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1001\/jamaoncol.2022.2970","article-title":"Association between prostate-specific antigen screening and prostate cancer mortality among non-hispanic black and non-hispanic white us veterans","volume":"8","author":"Sherer","year":"2022","journal-title":"JAMA Oncol"},{"issue":"2","key":"10.1016\/j.clgc.2025.102428_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellin.2025.100238","article-title":"Unveiling racial disparities in prostate cancer using an integrative genomic and transcriptomic analysis","volume":"4","author":"Elbialy","year":"2025","journal-title":"Cell Insight"},{"key":"10.1016\/j.clgc.2025.102428_bib0030","article-title":"Racial differences in the risk of second primary bladder cancer following radiation therapy among localized prostate cancer patients","volume":"73","author":"Zhang","year":"2021","journal-title":"Can Epidemiol"},{"issue":"11","key":"10.1016\/j.clgc.2025.102428_bib0031","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.42451","article-title":"Us cancer mortality trends among asian and pacific islander populations","volume":"7","author":"Zhu","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"14","key":"10.1016\/j.clgc.2025.102428_bib0032","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1002\/cncr.28697","article-title":"The rise and fall of prostate brachytherapy: use of brachytherapy for the treatment of localized prostate cancer in the National Cancer Data Base","volume":"120","author":"Martin","year":"2014","journal-title":"Cancer."},{"issue":"5","key":"10.1016\/j.clgc.2025.102428_bib0033","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.ijrobp.2020.11.055","article-title":"Influence of geography on prostate cancer treatment","volume":"109","author":"Tang","year":"2021","journal-title":"Int J Radiat Oncol Biol Physcs."},{"issue":"12","key":"10.1016\/j.clgc.2025.102428_bib0034","doi-asserted-by":"crossref","DOI":"10.5489\/cuaj.7173","article-title":"Incidence and mortality trends of metastatic prostate cancer: surveillance, Epidemiology, and End results database analysis","volume":"15","author":"Zhang","year":"2021","journal-title":"CUAJ"},{"issue":"4","key":"10.1016\/j.clgc.2025.102428_bib0035","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.ijrobp.2014.07.032","article-title":"Incidence of second malignancies in prostate cancer patients treated with low-dose-rate brachytherapy and radical prostatectomy","volume":"90","author":"Hamilton","year":"2014","journal-title":"Int J Radiat Oncol Biol Physcs."}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767325001284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767325001284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T21:08:32Z","timestamp":1770671312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767325001284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1558767325001284"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2025.102428","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Mortality Trends From Prostate Cancer and Associated Second Malignancies in the U.S., 1999 to 2023: Implications for Survivorship Care","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2025.102428","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102428"}}